Comparative Analyses of "Medical Marijuana" Laws in the United States
- *Corresponding Author:
- Norman S Miller
CEO of Health Advocates PLLC, East Lansing, MI
Clinical Professor of Psychiatry, Department of Psychiatry
Medical College of George, Augusta University
Augusta, Georgia, USA
Tel: (517) 507-0407
E-mail: [email protected]
Received date: November 21, 2016; Accepted date: January 09, 2017; Published date: January 16, 2017
Citation: Miller NS, Saad ZA (2017) Comparative Analyses of “Medical Marijuana” Laws in the United States. J Addict Res Ther S11:015. doi:10.4172/2155-6105.1000S11-015
Copyright: © 2017 Miller NS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The medical justification as to the risks and benefits associated with the use of marijuana for medical purposes is not supported by current medical research and state and federal laws in the United States. State endorsed “medical marijuana” currently take the form of a dried plant, cannabis sativa. State laws in favor of legalizing marijuana for medical use fail to incorporate the general legal standards for medical practice and are created absent any uniformed guidelines. These attempts to circumvent federal law lack the support of the medical and legal community as they overlook the standards for safety and effectiveness established by the Food and Drug Administration for medical use. With a growing public demand for marijuana, states have merely attempted to bypass the federal government’s current regulations on marijuana by legalizing such laws.